Question to the Department of Health and Social Care:

To ask His Majesty's Government why there is disparity in the legal prescribing rights of various professions when nurses, pharmacists, physiotherapists, podiatrists, therapeutic and diagnostic radiographers, dietitians and paramedics all undertake prescribing training together, and are assessed in the same way.

Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)

Non-medical prescribers must work within their own level of expertise. This, together with the requirements of the roles in which different professions are employed, is reflected in the differences between the legal prescribing responsibilities of these professions. Regulators keep records of which healthcare professionals can prescribe, and employers have a responsibility to ensure that non-medical prescribers undertake the relevant training and development, so that their knowledge and skills remain up to date. This is to ensure clinicians work within their sphere of competence.

Question to the Department of Health and Social Care:

To ask His Majesty's Government when they will respond to the report by the Patient Safety Commissioner The Hughes Report: Options for redress for those harmed by valproate and pelvic mesh, published on 7 February.

Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)

The Government is carefully considering the valuable work done by the Patient Safety commissioner and the resulting Hughes Report, which set out options for redress for those harmed by valproate and pelvic mesh. We will be providing an update to the Patient Safety Commissioner’s Report at the earliest opportunity.

Found: Members present: Lord Patel (The Chair); Baroness Blackstone; Viscount Colville of Culross; Baroness Cumberlege

Found: Members present: Lord Patel (The Chair); Baroness Blackstone; Viscount Colville of Culross; Baroness Cumberlege

Found: I will finish with a quote from Baroness Cumberlege in the medical devices safety review about all

Found: 2024 3.50 pm Watch the meeting Members present: Lord Patel (The Chair); Baroness Blackstone; Baroness Cumberlege

Found: 2024 3 pm Watch the meeting Members present: Lord Patel (The Chair); Baroness Blackstone; Baroness Cumberlege

Found: present: Baroness Wyld (In the Chair); Baroness Blackstone; Viscount Colville of Culross; Baroness Cumberlege

Found: report of the Independent Medicines and Medical Devices Safety Review (IMMDS) - led by Baroness Cumberlege

Found: concerns continue to meet dismissive attitudes, to the extent that over a decade after Darzi, Baroness Cumberlege

Found: Members present: Lord Patel (The Chair); Baroness Blackstone; Viscount Colville of Culross; Baroness Cumberlege

Found: Members present: Lord Patel (The Chair); Baroness Blackstone; Viscount Colville of Culross; Baroness Cumberlege

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential implications for his policies of the report by (a) Baroness Cumberlege entitled Independent Medicines and Medical Devices Safety Review, published 8 July 2020 and (b) Dr Henrietta Hughes entitled Options for redress for those harmed by valproate and pelvic mesh, published on 7 February 2024; and whether he plans to establish a taskforce to improve patient advocacy services for those affected by vaginal mesh implants.

Answered by Andrew Gwynne - Parliamentary Under-Secretary (Department of Health and Social Care)

The Independent Medicines and Medical Devices Safety Review’s overarching conclusion was that the system failed to listen to patients or put patients at the centre of their care. Subsequent work has focussed on improving how the system listens to and responds to concerns raised by patients, strengthening the evidence base on which decisions are made, including through making sure the right data is collected and used, and improving the safety of medicines and devices.

The Government is carefully considering the valuable work done by the Patient Safety Commissioner and the resulting Hughes Report, which builds on some of the issues identified by Baroness Cumberlege in the IMMDS Review. The Hughes Report sets out options for redress for those harmed by valproate and pelvic mesh, including a proposal on advocacy services. We will be providing an update to the Patient Safety Commissioner’s report at the earliest opportunity.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps his Department is taking to support those impacted by Primodos.

Answered by Andrew Gwynne - Parliamentary Under-Secretary (Department of Health and Social Care)

Primodos is one of three areas Baroness Cumberlege was asked to look into as part of her Independent Medicines and Medical Devices Review, which reported in 2020. Since the report was published, action has been taken to address the issues identified, including appointing the first Patient Safety Commissioner to champion patient voice in relation to the safety of medicines and medical devices.

Found: The Independent Medicines and Medical Devices Safety Review was chaired by Baroness Cumberlege.

Found: That could be fatal. ”688 Baroness Cumberlege was also firmly opposed, writing on 11 April 1995 that

Found: NHBT0005796 567 Lines to take on Hepatitis C Lookback Exercise p1 DHSC0003555_130 568 Letter from Baroness Cumberlege

Found: Reorganisations also inherently present short term inefficiencies and delay. ”139 In First Do No Harm , Baroness Cumberlege

Found: been highlighted by the 2020 Independent Medicines and Medical Device Safety Review led by Baroness Cumberlege

Found: NHBT0005796 567 Lines to take on Hepatitis C Lookback Exercise p1 DHSC0003555_130 568 Letter from Baroness Cumberlege

Found: Reorganisations also inherently present short term inefficiencies and delay. ”139 In First Do No Harm , Baroness Cumberlege

Found: That could be fatal. ”688 Baroness Cumberlege was also firmly opposed, writing on 11 April 1995 that

Found: medicines policy is progressing a SG response to the specialist centres recommendation from the Baroness Cumberlege

Found: stakeholder inputs, and produce a SG response to the specialist centres recommendation from the Baroness Cumberlege